Novel Machine Learning Model Improves MASLD Detection in Type 2 Diabetes
A machine learning–driven web tool based on 13 standard patient metrics demonstrates strong predictive performance for MASLD, supporting early clinical intervention.
An interpretable machine learning (ML) model can accurately predict metabolic dysfunction–associated steatotic liver disease (MASLD) in patients with type 2 diabetes mellitus (T2DM), a population at particularly high risk for liver complications.
MASLD is highly prevalent among adults with T2DM, affecting approximately 65%, and carries a substantially greater risk for progression to more severe liver diseases, including cirrhosis and hepatocellular carcinoma, compared with MASLD alone.
Author's summary: Novel ML model improves MASLD detection.
More News
- Meta Discounts Certified Refurbished Quest 3S to $216 Ahead of Black Friday
- Moonshadow Kitchen joins Sweet Farm in Himrod | Fingerlakes1.com
- WACKER Launches Bioengineered Growth Factor for Cultivated Meat - vegconomist - the vegan business magazine
- Industry welcomes “collaborative” approach to workplace health recommended by Mayfield review
- From the white Iberian lynx in Spain to the howler monkeys of Costa Rica: Why do animals change color?
- Government to join forces with employers to tackle ill-health
- Bridget Phillipson must not abandon special needs children | The Spectator Australia
- Roche Launches First AI-Enabled Continuous Glucose Monitor In South Africa - iAfrica.com
- At COP30, Africa can lead the way to a sustainable future — but will it? (commentary)
- WACKER Launches Bioengineered Growth Factor for Cultivated Meat - vegconomist - the vegan business magazine